Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
Clinical trial NCT05470283 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05470283
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-07
- Primary completion
- 2027-04-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.